Christina England
American Chronicle
07/04/2010

That is right, the American public are being encouraged by the FDA and CDC to inject their tiny babies aged 2 months, with a vaccine, that has been identified as being listed as a Category C drug. This devastating news was exposed by Richard Gale and Dr Gary Null in their article CDC Vote in Favor of a Flu Vaccination Assault on Americans Health

The article says:-

“The study investigated 90 approved drugs in the US (and let us make no mistake vaccines are drugs! In fact, the flu vaccine is listed as a Category C drug; which means there are no adequate safety studies to determine whether flu vaccination adversely affects pregnant mothers and their fetuses.) and discovered that 60 percent vaccination of the 900 papers were unpublished and some were concealed from the federal regulatory agencies. Forty to sixty percent omitted clinical details or changed their final their final analysis. Among the pharmaceutical industry alone, 94 percent were unpublished and 86 percent of the university studies sponsored by drug makers remained unpublished.”

This article was written by trusted authors and is proof that not only the Americans but the public worldwide, are to be force fed (if this vaccine becomes mandatory as planned) a category C drug. Well, that is, of course if we listen to the advice given to us by the FDA, CDC and the JCVI this year. The groups that are currently being targeted with this Category C drug are the elderly, persons with health disorders which include Asthma, heart and lung disease and those with lowered immune systems, pregnant women and vulnerable babies many of whom are premature.

Read the rest of the story.

Shari Roan
LA Times
07/02/2010

Flu viruses mutate rapidly, meaning that vaccines against the flu have to be continually updated to target the latest strains. Moreover, antiviral medications to combat flu sometimes become ineffective because of viral mutations. Thus, finding a so-called universal flu vaccine that could be used against a wide range of viruses over a longer period of time has been a long-held dream of medical experts and the subject of a lot of research.

Scientists reported this week that they have taken another step toward a possible universal flu vaccine. They discovered a target on the influenza A virus that has not changed much — unlike other regions of the virus — called influenza matrix 2 protein (M2e). The researchers then found rare, naturally occurring antibodies in humans that target the protein. When these antibodies were given to mice infected with influenza, 60% to 80% recovered compared to a 10% survival rate in the untreated mice. The antibodies protected against two influenza strains: seasonal human H1N1 and an avian flu, H5N1.

Read the rest of the article here.

Mike Swain
Mirror.co.uk
07/02/2010

The swine flu scare cost £1.2billion – as a vaccine firm cashed in.

The taxpayer footed the bill which included 20 million unused vaccines.

GlaxoSmithKline made £883million from sales of the drug last year but insisted the Government complete the deal even if the vaccines were no longer needed.

An independent report yesterday slammed the “inflexible” contracts.

Britain spent £654million preparing for a pandemic and £587million to respond to an H1N1 outbreak.

The £1.24billion total included £1.01billion on drugs, among them antivirals, vaccines and antibiotics. Between the outbreak, from April 2009 to March this year, there were 457 reported and confirmed swine flurelated deaths across the UK.

Read the rest of the article.

Donald G. McNeil, Jr.
The New York Times
06/17/2010

There is too little genetic surveillance of last year’s human pandemic flu, which has gone on to infect pigs in China and is readily mixing with other flus there, according to a study released Thursday by researchers in Hong Kong.

No dangerous new strain has emerged, said several experts who saw the study. But in January the researchers found a new strain with one of the pandemic flu’s surface proteins — the outer spikes and knobs it uses to attach to cells. That was a reminder of how easily another swine strain capable of spreading among people could emerge.

“Just because we’ve just had a pandemic does not mean we’ve decreased our chances of having another,” said Dr. Carolyn B. Bridges, an epidemiologist in the flu division of the Centers for Disease Control and Prevention. “We have to stay vigilant.”

Read the rest of the article.

Pritha Chatterjee
The Indian Express
06/06/2010

H1N1 Authorities say medics showed no interest in earlier vaccination

A day after the civic-run Kasturba Hospital received 2,000 doses of the indigenous H1N1 vaccine, doctors at the hospital admitted that the earlier batch of imported vaccines meant for vaccination of healthcare professionals remained untouched.

Union Health Minister Ghulam Nabi Azad inaugurated Vaxiflu-S, manufactured by Zydus Cadila, in New Delhi on Thursday. He had even taken a shot of it.

Read the rest of the article.